Under the agreement, Lonza is responsible to produce materials for Phase 2 trial at its mammalian development and manufacturing plant. IMMUNE claims its human immunoglobulin monoclonal antibody Bertilimumab
The trial aims to evaluate the tolerability, pharmacokinetics (PK) and safety of GLPG0492 on muscle function in healthy volunteers. Earlier, in a Phase I study in healthy volunteers,
Rib-X’s RX-04 program employs a proprietary approach for rational drug design resulting in entirely novel classes of compounds. Recently presented data confirmed the new compounds directly impact ribosome
P2D Bioscience has received a sum of $32,000 for establishing the efficacy of these drugs. The second phase of these studies will investigate the safety and pharmacokinetics of
As per the original agreement, Teva is responsible for marketing and distributing Multikine in Israel and Turkey, while the extended agreement allows Teva to include Croatia and Serbia.
Provantis is a modern, fully integrated Windows-based system for organizations and universities engaged in non-clinical evaluation studies. The submit solution suite converts data from any source system into
Robinson Pharma can now use the USP Verified Mark (DSVP) on its product labels, nutraingredients-usa.com reported. The approval has been granted for glucosamine-based joint health formulations which include
The launching of the drug is backed by the Japanese Ministry of Health, Labor and Welfare’s (MHLW) approval for edoxaban 15mg and 30mg tablets in April 2011. The
Unlike Viagra, Cialis and Levitra, Vitaros is applied directly to the penis as a cream. Vitaros contains a previously marketed ED drug – alprostadil. When absorbed through the
The patent covers the method of using intranasal administration of Ampligen with a seasonal influenza vaccine to boost immune response against a H5N1 avian influenza infection compared to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.